Cigna’s Acquisition of Express Scripts Cleared by DOJ

On September 17, Skadden obtained unconditional clearance from the Antitrust Division of the U.S. Department of Justice (DOJ) for Cigna Corporation’s proposed acquisition of our client Express Scripts Holding Company in a transaction valued at approximately $52 billion.